Patent · US Active

Human microRNAs for treatment of malignant tumours

US10556019B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

UNIVERSITÄTSKLINIKUM JENA · DE

Inventors

Ralf Mrowka · Jena, DE
Axel Gohring · Jena, DE

Key dates

Filing date	Aug 23, 2016
Grant date	Feb 11, 2020
Priority date	—
Expiry date	Aug 23, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/141
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a nucleic acid molecule for use in a method of treatment of cancer. The nucleic acid molecule comprises a sequence selected from SEQ ID NO 001 to SEQ ID NO 038. The nucleic acid molecules provided are not provided for the treatment of laryngeal cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.